First Time Loading...
T

Talis Biomedical Corp
NASDAQ:TLIS

Watchlist Manager
Talis Biomedical Corp
NASDAQ:TLIS
Watchlist
Price: 9.15 USD 0.55% Market Closed
Updated: May 5, 2024
Section:
 

Wall Street
Price Targets

TLIS Price Targets Summary
Talis Biomedical Corp

Wall Street analysts forecast TLIS stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TLIS is 5 USD .

TLIS Lowest Forecast
Wall Street Target
Not Available
TLIS Average Forecast
Wall Street Target
5 USD
45% Downside
TLIS Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
5 USD
45% Downside
Highest
Price Target
Not Available
Talis Biomedical Corp Competitors:
Price Targets
NARI
Inari Medical Inc
75% Upside
SHL
Siemens Healthineers AG
17% Upside
O
OPTOMED
Optomed Oyj
13% Upside
7733
Olympus Corp
10% Upside
NARI
Inari Medical Inc
75% Upside
SHL
Siemens Healthineers AG
17% Upside
O
OPTOMED
Optomed Oyj
13% Upside
7733
Olympus Corp
10% Upside
DIA
DiaSorin SpA
7% Upside
MDT
Medtronic PLC
17% Upside
IDXX
IDEXX Laboratories Inc
28% Upside
S
2252
Shanghai MicroPort MedBot Group Co Ltd
94% Upside

Revenue
Forecast

Revenue Estimate
Talis Biomedical Corp

For the last 3 years the compound annual growth rate for Talis Biomedical Corp's revenue is 7%. The projected CAGR for the next 3 years is 40%.

7%
Past Growth
40%
Estimated Growth
Estimates Accuracy
-9%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Talis Biomedical Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Talis Biomedical Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-25%
Average Miss
What are analyst estimates?

See Also

Summary
TLIS intrinsic value, competitors valuation, and company profile.
DCF Valuation
TLIS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TLIS stock valuation using valuation multiples.
Wall Street Estimates
TLIS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TLIS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TLIS's stock price target?
Price Target
5 USD

According to Wall Street analysts, the average 1-year price target for TLIS is 5 USD .

What is Talis Biomedical Corp's Revenue forecast?
Projected CAGR
40%

For the last 3 years the compound annual growth rate for Talis Biomedical Corp's revenue is 7%. The projected CAGR for the next 3 years is 40%.

ALPHA SPREAD
Join more than 134,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.